Fundamentals

Valuation

Metric	Q1	Q3	Δ in %
EV/EBITDA	2119.88	2537.13	114.29
Graham Fair Price	-45.37	0.72	1.32
PEG	363.65	1.81	-0.39
Price/Book	-3.74	1.06	1.10
Price/Cash Flow	58.83	-25.50	-61.93
Prices/Earnings	269.72	-196.41	53.13
Price/Sales	0.72	5.55	5.51
Price/FCF	58.83	-25.50	-61.93
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q3	Δ in %
Gross Profit Margin	58.34	0.13	0.08
Operating Margin	653.04	-0.01	< 0.005
ROA	-74.83	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-73.96
ROIC	< 0.005	< 0.005	526.52
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q3	Δ in %
Debt QOQ	-0.90	-0.76	-17.93
Dividends QOQ	-0.61	0.03	-95.68
EBIT QOQ	1.02	-1.17	15.04
EPS QOQ	1.36	-1.09	-20.26
FCF QOQ	-1.29	-1.90	-47.03
Revenue QOQ	0.09	-0.21	151.08
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	48.87	48.47	-0.82
Days Sales Outstanding (DSO)	66.96	12.63	-81.14
Inventory Turnover	1.84	1.86	0.82
Debt/Capitalization	0.10	0.04	-60.22
Quick Ratio	1.48	1.43	-3.71
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q3	Δ in %
Book Value	3.85	4.13	7.16
Cash	2.16	2.55	17.71
Capex	-0.08	0.05	-38.49
Free Cash Flow	-0.07	-0.17	-150.33
Revenue	0.77	0.79	2.32
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q3	Δ in %
Current Ratio	1.70	1.59	-6.68
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-34.28	-1097.35	-3100.88
Naive Interpretation	Member

06 - Financial Health · Weak

Rating